You have 9 free searches left this month | for more free features.

Pyoderma

Showing 1 - 25 of 236

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pyoderma Gangrenosum Trial in New York (Spesolimab)

Recruiting
  • Pyoderma Gangrenosum
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 16, 2023

Pyoderma Gangrenosum Trial (Platelet rich plasma therapy)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Platelet rich plasma therapy
  • (no location specified)
Aug 2, 2023

Pyoderma Gangrenosum Trial (IFX-1, Placebo)

Not yet recruiting
  • Pyoderma Gangrenosum
  • (no location specified)
Jul 28, 2023

Pyoderma Gangrenosum Trial in Lebanon (Deucravacitinib)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Apr 6, 2023

Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

Active, not recruiting
  • Pyoderma
  • +3 more
  • Monoclonal antibody (Mab) sB24M
  • Minsk, Belarus
  • +1 more
Jul 8, 2022

Pyoderma Gangrenosum Trial (Hyperbaric oxygen, Control group)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Hyperbaric oxygen
  • Control group
  • (no location specified)
Jul 14, 2022

Pyoderma Gangrenosum Trial in Gahanna (Ixekizumab)

Completed
  • Pyoderma Gangrenosum
  • Ixekizumab
  • Gahanna, Ohio
    The Ohio State University Dermatology
May 11, 2022

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Not yet recruiting
  • Pyoderma Gangrenosum
  • +2 more
  • immunohistochemical methods
  • (no location specified)
Mar 21, 2022

Pyoderma Gangrenosum Trial in Stanford (Humira)

Withdrawn
  • Pyoderma Gangrenosum
  • Stanford, California
    Stanford University
Feb 3, 2022

Pyoderma Gangrenosum Trial in Metairie, New Orleans (Dehydrated human amnion/chorion membrane)

Recruiting
  • Pyoderma Gangrenosum
  • Dehydrated human amnion/chorion membrane
  • Metairie, Louisiana
  • +2 more
Nov 9, 2021

Pyoderma Gangrenosum, Skin Diseases, Wound Heal Trial in Portland (Baricitinib)

Recruiting
  • Pyoderma Gangrenosum
  • +4 more
  • Portland, Oregon
    Oregon Health and Science University
Sep 8, 2021

Pyoderma Gangrenosum Trial (secukinumab 150 mg (2 injections per dose)

Withdrawn
  • Pyoderma Gangrenosum
  • secukinumab 150 mg (2 injections per dose
  • (no location specified)
May 25, 2021

Disease State in Adult Participants Being Treated With Humira in

Recruiting
  • Pyoderma Gangrenosum
    • Nagoya shi, Aichi, Japan
    • +44 more
    Jan 13, 2023

    Pyoderma Gangrenosum Trial in Tallahassee (Xilonix)

    Completed
    • Pyoderma Gangrenosum
    • Xilonix
    • Tallahassee, Florida
      XBiotech Investigative Site
    Jan 26, 2021

    Pyoderma Gangrenosum Trial in Japan (adalimumab)

    Completed
    • Pyoderma Gangrenosum
    • Nagoya-shi, Aichi, Japan
    • +19 more
    Mar 5, 2021

    Pyoderma Gangrenosum Trial in Munich (Secukinumab)

    Unknown status
    • Pyoderma Gangrenosum
    • Munich, Germany
      Technical University of Munich
    Feb 17, 2020

    Pyoderma Gangrenosum Trial in Winston-Salem (adalimumab)

    Withdrawn
    • Pyoderma Gangrenosum
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences Dermatology
    Dec 17, 2019

    Chronic Ulcer of Skin Trial in Tampere (Thermal imaging in diagnostics of chronic ulcers)

    Enrolling by invitation
    • Chronic Ulcer of Skin
    • Thermal imaging in diagnostics of chronic ulcers
    • Tampere, Finland
      Tampere University Hospital
    Jul 3, 2023

    Streptococcus Pyogenes Carriage Acquisition and Transmission

    Completed
    • Group A Streptococcal Infection
    • +2 more
      • Fajara, Gambia
        MRC Unit The Gambia at LSHTM
      Nov 21, 2022

      Inflammatory Marker in Ibd and Peripheral Arthritis

      Not yet recruiting
      • IBD-Inflammatory Bowel Disease
        • (no location specified)
        Jan 20, 2023

        Ulcerative Colitis, Crohn Disease Trial in Surat (Vedolizumab IV)

        Active, not recruiting
        • Ulcerative Colitis
        • Crohn Disease
        • Vedolizumab IV
        • Guntur, Andhra Pradesh, India
        • +17 more
        Jan 26, 2023

        Cutaneous Diphtheria in France : Observational, Retrospective

        Not yet recruiting
        • Corynebacterium Diphtheriae Infection
        • Characteristics description
        • Toulon, VAR, France
          HIA Sainte Anne
        Apr 3, 2023

        Comorbidities and Pathologies Associated With Pyoderma

        Unknown status
        • Pyoderma Gangrenosum
        • pathology associated
        • Marseille, Paca, France
          Assistance Publique Des Hopitaux de Marseille
        Aug 17, 2018

        Gliflozins on HF in Regurgitant Rheumatic Heart

        Not yet recruiting
        • Rheumatic Heart Disease
        • Heart Failure
        • SGLT2 inhibitor
        • (no location specified)
        Oct 27, 2023